MedRhythms snatches up $25m Series B

MedRhythms, a developer of prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, has raised $25 million in Series B financing.

MedRhythms, a developer of prescription digital therapeutics that use sensors, software, and music to measure and improve walking for patients with a neurologic injury or disease, has raised $25 million in Series B financing. Morningside Ventures and Advantage Capital, led the round with participation from existing investor Werth Family Investment Associates.

Source: Press Release